"Antiprotozoal Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that are destructive to protozoans.
Descriptor ID |
D000981
|
MeSH Number(s) |
D27.505.954.122.250.100
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antiprotozoal Agents".
Below are MeSH descriptors whose meaning is more specific than "Antiprotozoal Agents".
This graph shows the total number of publications written about "Antiprotozoal Agents" by people in this website by year, and whether "Antiprotozoal Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 1 | 0 | 1 |
2006 | 2 | 0 | 2 |
2007 | 1 | 1 | 2 |
2008 | 1 | 0 | 1 |
2010 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antiprotozoal Agents" by people in Profiles.
-
Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections. Molecules. 2020 Nov 01; 25(21).
-
Leishmania donovani: influence of anti-leishmanial therapy on expression of lymphocyte function-associated antigen-3 and its relevance to pathogenisis in visceral leishmaniasis. Hum Immunol. 2013 Dec; 74(12):1575-8.
-
Hidden in plain view: emergence of progressive multifocal leukoencephalopathy after treatment of CNS toxoplasmosis. Acta Neurol Belg. 2011 Sep; 111(3):217-9.
-
Acanthamoeba endophthalmitis following penetrating keratoplasty for Acanthamoeba keratitis. Arch Ophthalmol. 2010 Apr; 128(4):505-6.
-
Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy. Arch Ophthalmol. 2008 Aug; 126(8):1152-6.
-
Cataracts in congenital toxoplasmosis. J AAPOS. 2007 Dec; 11(6):551-4.
-
Longitudinal study of new eye lesions in treated congenital toxoplasmosis. Ophthalmology. 2008 Mar; 115(3):553-559.e8.
-
Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis. 2006 May 15; 42(10):1383-94.
-
Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis. Pediatr Infect Dis J. 2006 Mar; 25(3):270-2.
-
Antileishmanial activity of isolated triterpenoids from Pourouma guianensis. Phytomedicine. 2004 Feb; 11(2-3):114-20.